ARPA-H Allocates $62 Million for AI Innovations in Heart Failure Treatment
By Editor • September 9, 2026 • 1 min read
The Advanced Research Projects Agency for Health (ARPA-H) has announced an ambitious investment of $62.7 million aimed at developing artificial intelligence solutions to enhance the treatment of heart failure. This initiative, named ADVOCATE, seeks to create FDA-authorized AI systems that can autonomously assist in patient care by evaluating symptoms, prescribing medications, and managing lab tests.
On Wednesday, ARPA-H unveiled its initial round of funding recipients, which includes health tech firms like Atman Health, UpDoc, and Tempus AI, as well as collaborative teams from prestigious institutions such as Stanford University, Duke University, and the Kaiser Permanente health system. The agency has allocated $33.7 million for the first year, with the potential for further funding adjustments in the future.
This funding comes at a critical time, as approximately 6.7 million Americans suffering from heart failure often face challenges in accessing specialized care. The hope is that the advancements in AI technology supported by ARPA-H will bridge this gap, particularly for patients in rural and underserved areas.
Source: www.statnews.com
#AI technology #ARPA-H #FDA #healthcare funding #heart failure
